Clinical Trial Update: Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the uric acid‑lowering activity, safety, and pharmacokinetic interaction of oral BCX4208 with allopurinol in subjects with gout has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Allopurinol (Allopurinol)
• BCX4208 (BCX4208)

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Gout | Phase 2 | Status: COMPLETED